Referenties

Ellelu MS, Khaza’ai H, Abed Y, Rahmat A, Ismail P, Ranneh Y. 2015. Role of fish oil in human health and possible

mechanism to reduce inflammation.

Ruyter B, Grimmer S, Thorkildsen T, Todorcevic M, Lalic M, Vogt G. 2010. Lite oksiderte omega-3 oljer og potensielle

helsefordeler. En screening av omega-3 oljer med hensyn til variasjon i oksidasjonsgrad, innhold av oksidasjonsprodukter

og effect på markørsystemer. RUBIN-rapport 196. Trondheim: RUBIN.

García-Hernández VM, Gallar M, Sánchez-Sorino J, Micol V, Roche E, García-García E. 2013. Effect of omega-3

dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial.

Int J Food Sci Nutr 64(8), 993−1000.

Jackowski SA, Alvi AZ, Mirajkar A, Imani Z, Gamalevych Y. 2015. Oxidation levels of North American over-the-counter

n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative

safety. J Nutr Sci 4, e30.

Ruyter B, Grimmer S, Thorkildsen T, Todorcevic M, Lalic M, Vogt G. 2010. Lite oksiderte omega-3 oljer og potensielle 

helsefordeler. En screening av omega-3 oljer med hensyn til variasjon i oksidasjonsgrad, innhold av oksidasjonsprodukter

og effect på markørsystemer. RUBIN-rapport 196. Trondheim: RUBIN.

Albert BB, Derraik JGB, Cameron-Smith D, Hofman PL, Tumanov S, Villas-Boas SG, et al. 2015. Fish oil supplements

in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep 5, 7928.

Opperman M, Benade S. 2013. Analysis of the omega-3 fatty acid content of South African fish oil supplements:

a follow-up study. Cardiovasc J Afr 24, 297−302.

Rupp TP, Rupp KG, Alter P, Rup H. 2013. Replacement of reduced highly unsaturated fatty acids (HUFA deficiency) in

dilative heart failure: dosage of EPA/DHA and variability of adverse peroxides and aldehydes in dietary supplement

fish oils. Cardiology 125, 223−231. 

García-Hernández VM, Gallar M, Sánchez-Sorino J, Micol V, Roche E, García-García E. 2013. Effect of omega-3

dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial.

Int J Food Sci Nutr 64(8), 993−1000.

Awada M, Soulage CO, Meynier A, Debard C, Plaisancié P, Benoit B, et al. 2012. Dietary oxidized n-3 PUFA induce

oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells. J Lipid Res

53, 2069−2080.

Grimm MOW, Haupenthal VJ, Mett J, Stahlmann CP, Blümel T, Mylonas NT, et al. 2015. Oxidized Docosahexaenoic

acid species and lipid peroxidation products increase amyloidogenic amyloid precursor protein processing.

Neurodegener Dis 16, 44−54.

Wilson R, Lyall K, Millar EM, Smyth L, Pearson C, Riemersma RA. 2003. Do oxidized fatty acids activate Coagulation

factor VII during postprandial lipemia in woman? Thromb Haemost 89, 654−659.

Ruyter B, Grimmer S, Thorkildsen T, Todorcevic M, Lalic M, Vogt G. 2010. Lite oksiderte omega-3 oljer og potensielle 

helsefordeler. En screening av omega-3 oljer med hensyn til variasjon i oksidasjonsgrad, innhold av oksidasjonsprodukter

og effect på markørsystemer. RUBIN-rapport 196. Trondheim: RUBIN.

García-Hernández VM, Gallar M, Sánchez-Sorino J, Micol V, Roche E, García-García E. 2013. Effect of omega-3 

dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial. 

Int J Food Sci Nutr 64(8), 993−1000.

Ghasemifard S, Turchini GM, Sinclair AJ. 2014. Omega-3 long chain fatty acid “bioavailability”: A review of evidence

and methodological considerations. Prog Lipid Res 56, 92−108.

Jackowski SA, Alvi AZ, Mirajkar A, Imani Z, Gamalevych Y. 2015. Oxidation levels of North American over-the-counter   

n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative

safety. J Nutr Sci 4, e30.

Ruyter B, Grimmer S, Thorkildsen T, Todorcevic M, Lalic M, Vogt G. 2010. Lite oksiderte omega-3 oljer og potensielle 

helsefordeler. En screening av omega-3 oljer med hensyn til variasjon i oksidasjonsgrad, innhold av oksidasjonsprodukter

og effect på markørsystemer. RUBIN-rapport 196. Trondheim: RUBIN.

Albert BB, Derraik JGB, Cameron-Smith D, Hofman PL, Tumanov S, Villas-Boas SG, et al. 2015. Fish oil supplements

in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep 5, 7928.

Opperman M, Benade S. 2013. Analysis of the omega-3 fatty acid content of South African fish oil supplements:

a follow-up study. Cardiovasc J Afr 24, 297−302.

Rupp TP, Rupp KG, Alter P, Rup H. 2013. Replacement of reduced highly unsaturated fatty acids (HUFA deficiency) in

dilative heart failure: dosage of EPA/DHA and variability of adverse peroxides and aldehydes in dietary supplement

fish oils. Cardiology 125, 223−231. 

García-Hernández VM, Gallar M, Sánchez-Sorino J, Micol V, Roche E, García-García E. 2013. Effect of omega-3

dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial.

Int J Food Sci Nutr 64(8), 993−1000.

Awada M, Soulage CO, Meynier A, Debard C, Plaisancié P, Benoit B, et al. 2012. Dietary oxidized n-3 PUFA induce

oxidative stress and inflammation: role of intestinal absorption of 4-HHE and reactivity in intestinal cells. J Lipid Res

53, 2069−2080.

Grimm MOW, Haupenthal VJ, Mett J, Stahlmann CP, Blümel T, Mylonas NT, et al. 2015. Oxidized Docosahexaenoic

acid species and lipid peroxidation products increase amyloidogenic amyloid precursor protein processing.

Neurodegener Dis 16, 44−54.

Wilson R, Lyall K, Millar EM, Smyth L, Pearson C, Riemersma RA. 2003. Do oxidized fatty acids activate Coagulation

factor VII during postprandial lipemia in woman? Thromb Haemost 89, 654−659.

Lawson LD, Hughes BG. 1988a. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters.

Biochem Biophys Res Commun 152 (Suppl 1), S328−S335.

Beckermann B, Beneke M, Seitz I. 1990. Comparative bioavailability of eicosapentaenoic acid and docosahexaenoic

acid from triglycerides, free fatty acids and ethyl esters in volunteers. Arzneimittelforschung 40 (Suppl 6), S700−704.

Ghasemifard S, Turchini GM, Sinclair AJ. 2014. Omega-3 long chain fatty acid “bioavailability”: A review of evidence

and methodological considerations. Prog Lipid Res 56, 92−108.

www.fisheries.no, de officiële website van Noorwegen voor informatie over voedselveiligheid van zeevoedsel en visserij-

en aquacultuurbeheer.

www.seafood.no, de Noorse Raad van Zeevoedsel.

Strobel C, Jahreis G, Kuhnt K. 2012. Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids

Health Dis 11, 144.

www.fisheries.no, de officiële website van Noorwegen voor informatie over voedselveiligheid van zeevoedsel en visserij- 

en aquacultuurbeheer.

www.seafood.no, de Noorse Raad van Zeevoedsel.

Muskiet FAJ. 2010. Pathophysiology and evolutionary aspects of dietary fats and long-chain polyunsaturated fatty acids   

across the life cycle. In: Montmayeur JP, le Coutre J, editors. Fat detection: taste, texture, and post ingestive effects.      

Boca Raton (FL), CRC Press.

Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J. 2012. Long chain omega-3 fatty acids and cardiovascular disease:  

a systematic review. British Journal of Nutrition 107, S201−S213.

Geurts M, Beukers M, Buurma-Rethans E, Van Rossum CTM. 2015. Memo: Consumptie van een aantal

voedingsmiddelengroepen en nutriënten door de Nederlandse bevolking. Resultaten van VCP 2007-2010. Bilthoven:

RIVM.

Ellelu MS, Khaza’ai H, Abed Y, Rahmat A, Ismail P, Ranneh Y. 2015. Role of fish oil in human health and possible

mechanism to reduce inflammation. Inflammopharmacol 23, 79−89.

Endo J, Arita M. 2016. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. Journal of Cardiology 67, 22−

27.

Kakoti BB, Hernandez-Ontiveros DG, Kataki MS, Shah K, Pathak Y, Panguluri SK. 2015. Resveratrol and omega-3 fatty

acid: its implications in Cardiovascular diseases. Front Cardiovasc Med 2, 38.

Chaddha A, Eagle KA. 2015. Omega-3 fatty acids and heart health. Circulation 132, e350−e352.

Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. 1999. Dietary supplementation with n-3

polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354,

447−455.

Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association, Nutrition Committee. 2002. Fish consumption, fish

oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747−2757.

Leslie MA, Cohen DJA, Liddle DM, Robinson LE, MA DWL. 2015. A review of the effect of omega-3 polyunsaturated

fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids in

Health and Disease 14, 53.

La Rovere MT, Christensen JH. 2015. The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs.

Vascular Pharmacology 71, 1−10.

Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J. 2012. Long chain omega-3 fatty acids and cardiovascular disease:

a systematic review. British Journal of Nutrition 107, S201−S213.

Weiser MJ, Butt CM, Mohajeri MH. 2016. Docosahexaenoic acid and cognition throughout the lifespan. Nutrients 8(2), 99. 

Denis I, Potier B, Heberden C, Vancassel S. 2015. Omega-3 polyunsaturated fatty acids and brain aging. Curr Opin Clin

Nutr Metab Care 18(2), 139−146.

Janssen CIF, Kiliaan AJ. 2014. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the

influence of LCPUFA on neural development, aging, and neurodegeneration. Progress in Lipid Research 53, 1−17.

Joffre C, Nadjar A, Lebbadi M, Calon F, Laye S. 2014. n-3 LCPUFA improves cognition: the young, the old and the sick.  

Prostaglandins, Leukotrienes and Essential Fatty Acids 91, 1−20.

Pinazo-Durán MD, Gómez-Ulla F, Arias L, Araiz J, Casaroli-Marano R, Gallego-Pinazo R et al. 2014. Do nutritional      

supplements have a role in age macular degeneration prevention? Journal of Ophthalmology 2014, 901686.

Querques G, Souied EH. 2014. The role of omega-3 and micronutrients in age-related macular degeneration. Survey of     

Ophthalmology 59, 532−539.

Schleicher M, Weikel K, Garber C, Taylor A. 2013. Diminishing risk for age-related macular degeneration with nutrition: a 

current view. Nutrients 5(7), 2405−2456

Lorente-Cebrián S, Costa AGV, Navas-Carretero S, Zabala M, Laiglesia LM, Martinés JA et al. 2015. An update on the        

role of omega-3 fatty acids on degenerative dise ases. J Physiol Biochem 71, 341 − 349.

Ellelu MS, Khaza ’ ai H, Abed Y, Rahmat A, Ismail P, Ranneh Y. 2015. Role of fish oil in human health and possible               

mechanism to reduce inflammation. Inflammopharmacol 23, 79 − 89.

Yates CM, Calder PC, Rainger GED. 2014. Pharmacology and therapeutics of omega- 3 polyunsaturated fatty acids in 

chronic inflammatory disease. Pharmacology and Therapeutics 141 (3), 272 − 282.

Miles EA, Calder PC. 2012. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic 

review of their effects on clinical outcomes in rheumatoid arthritis. British Journal of Nutrition 107(S2), S171−S184. 

Manzi L, Costantini L, Molinari R, Merendino N. 2015. Effect of dietary ω-3 polyunsaturated fatty acid DHA on glycolytic  

enzymes and Warburg phenotypes in Cancer. BioMed Research International 2015, 137097.

Cockbain AJ, Toogood GJ, Hull MA. 2012. Omega-3 polyunsaturated fatty acids for the treatment and prevention of          

colorectal cancer. Gut 61, 135−149. doi:10.1136/gut.2010.233718

Gleissman H, Johnsen JI, Kogner P. 2010. Omega-3 fatty acids in cancer, the protectors of good and the killers of 

evil? Experimental Cell Research 316, 1365−1373.

Müller CP, Reichel M, Mühle C, Rhein C, Gulbins E, Kornhuber J. 2015. Brain membrane lipids in major depression and    

anxiety disorders. Biochimica et Biophysica Acta 1851(8), 1052−1065.

Vesco AT, Lehmann J, Gracious BL, Arnold LE, Young AS, Fristad MA. 2015. Omega-3 supplementation for psychotic

mania and comorbid anxiety in children. Journal of Child and Adolescent Psychopharmacology 25(7), 526−534.

Mello AH, Gassenferth A, Souza LR, Fortunato JJ, Rezin GT. 2014. ω-3 and major depression: a review. Acta

Neuropsychiatrica 26(3), 178−185.

Weiser MJ, Butt CM, Mohajeri MH. 2016. Docosahexaenoic acid and cognition throughout the lifespan. Nutrients 8(2),     

99.

Emmett PM, Jones LR, Golding J. 2015. Pregnancy diet and associated outcomes in the Avon longitudinal study of

parents and children. Nutrition Reviews 73(S3), 154−174.

Harris W, Baack M. 2015. Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity. J

Perinatol 35, 1−7.

Koren N, Simsa-Maziel S, Shahar R, Schwartz B, Monsonego-Ornan E. 2014. Exposure to omega-3 fatty acids at early

age accelerate bone growth and improve bone quality. Journal of Nutritional Biochemistry 25(6), 623−633.

De Giuseppe R, Roggi C, Cena  H. 2014. N-3 LC-PUFA supplementation: effects on infants and maternal outcomes. Eur

J Nutr 53(5), 1147−1154.

Rogers LK, Valentine CJ, Keim SA. 2013. DHA supplementation: current implications in pregnancy and childhood.

Pharmacol Res 70(1), 13−19.

Huhn S, Masouleh SK, Stumvoll M, Villringer A, Witte AV. 2015. Components of a Mediterranean diet and their impact    

on cognitive functions in aging. Frontiers in Aging Neuroscience 7, 132.

Yurko-Mauro K, Alexander DD, Van Elswyk ME. 2015. Docosahexaenoic acid and adult memory: A systematic review    

and meta-analysis. PLoS ONE 10(3): e0120391.

Molfino A, Gioia G, Fanelli FR, Muscaritoli M. 2014. The role for dietary omega-3 fatty acids supplementation in older

adults. Nutrients 6(10), 4058−4072.

Mangano KM, Sahni S, Kerstetter JE, Kenny AM, Hannan MT. 2013. Folyunsaturated fatty acids and their relation with

bone and muscle health in adults. Curr Osteoporos Rep 11(3), 203−2012.

Thomas J, Thomas CJ, Radcliffe J, Itsiopoulos C. 2015. Omega-3 fatty acids in early prevention of inflammatory            

neurodegenerative disease: a focus on Alzheimer’s disease. BioMed Research International, 172801.

Dyall SC. 2015. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA,

DPA and DHA. Frontiers in Aging Neuroscience 7, 52.

Bousquet M, Calon F, Cicchetti F. 2011. Impact of omega-3 fatty acids in Parkinson’s disease. Ageing Research Reviews   

10, 453−463.

Gow RV, Hibbeln JR, Parletta N. 2015. Current evidence and future directions for research with omega-3 fatty acids and

attention deficit hyperactivity disorder. Curr Opin Clin Nutr Metab Care 18, 133−138.

Gow RV, Hibbeln JR. 2014. Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood

behaviors. Child Adolesc Psychiatric Clin N Am 23, 555−590.

Bloch MH, Mulqueen J. 2014. Nutritional supplements for the treatment of ADHD. Child Adolesc Psychiatric Clin N Am

23, 883−897.

Frensham LJ, Bryan J, Parletta N. 2012. Influences of micronutrient and omega-3 fatty acid supplementation on

cognition, learning, and behaviour: methodological considerations and implications for children and adolescents in

developed societies. Nutrition Reviews 70(10), 594−610.

Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ. 2013. Low blood long chain omega-3 fatty acids   

in UK children are associated with poor cognitive performance and behavior: a cross-sectional analysis from the

DOLAB study. PLoS ONE 8(6), e66697.

Lindmark L, Clough P. 2007 . A 5 month open study with long-chain polyunsaturated fatty acids in Dyslexia. Journal of

Medicinal Food 10(4), 662 − 666.

Millsop JW, Bhatia BK, Debbaneh M, Koo J, Liao W. 2014. Diet and psoriasis: part 3. Role of nutritional supplements. J    

Am Acad Dermatol 71(3), 561−569.

Pilkington SM, Watson REB, Nicolaou A, Rhodes LE. 2011. Omega-3 polyunsaturated fatty acids: photoprotective

macronutrients. Experimental Dermatology 20(70), 537−543.